Header Logo
Newsletter Podcast
Log In
← Back to all posts

Real Results with PRP, Staff Scripts That Work, and Events You’ll Love

May 06, 2025
Connect

Highlights

  • Today’s Research Article: PRP wins the long game — outperforms kinesiotaping for chronic heel pain with lasting relief and tissue regeneration.
  • Questions from the Field: Can you combine PRP and protein concentrate for osteoarthritis? Absolutely — and here’s why it works.
  • Let’s Get Down to Business: Your front desk is your secret salesforce — train them to sell PRP with empathy, not just prices.
  • Come Join Us: Get hands-on with regenerative medicine — meet us live at top events this May and July.

If this newsletter was forwarded to you and you'd like to receive future updates directly, subscribe here.


Today’s Research Article

Regenerative efficacy of therapeutic quality platelet‐rich plasma injections versus phonophoresis with kinesiotaping for the treatment of chronic plantar fasciitis: A prospective randomized pilot study

Nitesh Gonnade, Archana Bajpayee, Abhay Elhence, Vaibhav Lokhande, Neeraj Mehta, Manish Mishra, Arunpreet Kaur

Read the full article here.

Summary:

This prospective randomized pilot study compared the long-term regenerative efficacy of autologous platelet-rich plasma (PRP) injections versus phonophoresis with kinesiotaping (KT) in patients with chronic plantar fasciitis unresponsive to conservative treatments. Out of 64 enrolled patients, 54 completed the 24-week follow-up. While KT provided better early pain relief at 2 weeks, PRP showed significantly greater improvements in pain (Numerical Rating Scale), foot function (Foot Function Index), and plantar fascia thickness at 12 and 24 weeks. The study used two ultrasound-guided PRP injections spaced two weeks apart, with a standardized preparation method ensuring high platelet concentration and minimal contamination.

The results support that PRP not only reduces symptoms but also promotes tissue regeneration in plantar fasciitis. Unlike KT, whose benefits were short-lived, PRP demonstrated sustained pain relief and structural improvement over six months, with no reported adverse effects. The study suggests that therapeutic-quality PRP injections can be a viable, cost-effective, and safer long-term option for managing chronic plantar fasciitis, especially in patients who have not responded to traditional therapies.

Doctor-to-Patient Talking Points on Why to Choose PRP (Based on the Study):

Subscribe to keep reading this post

Subscribe

Already have an account? Log in

Loading...
PRP That Lasts, Better Mentorship, and What’s Next in Vegas
Highlights Today’s Research Article: PRP proves its power—lasting relief for knees, even 7 years later. Questions from the Field: When PRP isn't enough, protein concentrate might be the missing link. Let’s Get Down to Business: The right mentor can transform your clinic—and your confidence. Come Join Us: Level up your skills and strategy—join us live in Las Vegas this July and August. If thi...
Better Outcomes, Better Marketing, Bigger Impact
Highlights Today’s Research Article: PRP Outperforms Steroids in Knee OA Relief and the Results Last. Questions from the Field: It’s Not the Centrifuge, It’s What You Do With It. Let’s Get Down to Business: Stop blending in. Learn how patient stories and consistency can turn followers into patients. Come Join Us: Join us in Vegas this July and August for two powerful regenerative medicine exp...
MRI-Proven PRP Wins, Patient Talk Tracks and Big Wins for Your Bottom Line
Highlights Today’s Research Article: PRP Outperforms Steroids in Joint Healing — MRI-Proven. Questions from the Field: PRP = Fewer Replacements, Longer Relief — Even Years Later. Let’s Get Down to Business: Boost Practice Revenue with Cash-Based Services Patients Want. Come Join Us: Learn, Network, and Level Up — See You in Vegas!   If this newsletter was forwarded to you and you'd like to r...

The OBX Brief

Your guide to Orthobiologics Literature
Footer Logo
Newsletter Podcast
© 2025 Kajabi
Powered by Kajabi

Join Our Free Trial

Get started today before this once in a lifetime opportunity expires.